INTELLIGENT BIO SOLUTIONS INC. Business Acquisition, Pro Forma Revenue
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Business Acquisition, Pro Forma Revenue of $1.26 million for the 12-month period ending 2023-06-30, per its 10-K filed 2024-09-18.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2024-09-18
- INTELLIGENT BIO SOLUTIONS INC. business acquisition, pro forma revenue for the quarter ending 2023-06-30 was $443.13K.
- INTELLIGENT BIO SOLUTIONS INC. business acquisition, pro forma revenue for the quarter ending 2023-03-31 was $457.06K.
- INTELLIGENT BIO SOLUTIONS INC. business acquisition, pro forma revenue for fiscal 2023 was $1.26M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2023-06-30 | $443.13K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $900.19K derived: sum of 2 quarters · filed 2024-09-18 | $1.26M 10-K · filed 2024-09-18 | |
| 2023-03-31 | $457.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $813.74K 10-Q · filed 2024-05-08 | ||
| 2022-12-31 | $356.68K 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |